Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Verrica Pharmaceuticals Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 57 | 49 | −8 |
| Shares | 11.3M | 10.2M | −1.08M (−9.6%) |
| Value | $21.8M | $29.9M | +$8.16M (+37.5%) |
New holders (6)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna Fundamental Investments, LLC | 28,000 | $82.0K | 0.00% |
| LPL Financial LLC | 22,000 | $64.0K | 0.00% |
| Creative Planning | 14,781 | $43.0K | 0.00% |
| Charles Schwab Investment Management Inc | 12,572 | $37.0K | 0.00% |
| Two Sigma Advisers, LP | 12,600 | $37.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 385 | $1.00K | 0.00% |
Sold out (14)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| CVI Holdings, LLC | 450,000 | $864.0K |
| Ergoteles LLC | 64,300 | $123.0K |
| Dimensional Fund Advisors LP | 26,193 | $50.0K |
| XTX Topco Ltd | 25,795 | $50.0K |
| Squarepoint Ops LLC | 18,808 | $36.0K |
| Boothbay Fund Management, LLC | 16,667 | $32.0K |
| Ground Swell Capital, LLC | 10,205 | $20.0K |
| Jane Street Group, LLC | 10,579 | $20.0K |
| Spire Wealth Management | 3,827 | $7.00K |
| Legal & General Group Plc | 1,102 | $2.00K |
| Federated Hermes, Inc. | 931 | $2.00K |
| New York State Common Retirement Fund | 128 | $0 |
| Credit Suisse AG | 7 | $0 |
| CoreCap Advisors, LLC | 200 | $0 |